Leonardo Maia Leony (LM Leony) is a biomedical scientist with advanced training in Investigative Medicine (MSc, PhD) and a strong focus on diagnostic development, immunopathology, and infectious disease surveillance. He is a professor of pathology in a medical school and a research fellow at Fiocruz and at the University of São Paulo Medical School (FM-USP). His background includes academic training in stem cells and regenerative biology at Harvard University. His research centers on serological and point-of-care diagnostics, particularly design and evaluation of recombinant antigens, ELISAs, and lateral flow immunoassays. He has contributed to platforms for SARS-CoV-2 serology and currently works on multiband LFIA technologies and developing novel conjugated nanoparticles. He was part of the team responsible for the TR Chagas (Bio-Manguinhos) development, considered the most reliable and advanced LFIA for Chagas disease screening. Dr. Leony’s expertise integrates immunology, host–pathogen interactions, and analytical validation, with emphasis on antibody profiling, assay performance, and translational applicability. He also teaches pathology and laboratory medicine, promoting mechanistic understanding of disease through integration of morphology and diagnostic reasoning.